News
BSX
97.27
+1.87%
1.79
If You Invested $100 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today
Benzinga · 4h ago
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
NASDAQ · 6h ago
Boston Scientific price target lowered to $112 from $113 at Evercore ISI
TipRanks · 1d ago
Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)
TipRanks · 1d ago
Weekly Report: what happened at BSX last week (1229-0102)?
Weekly Report · 1d ago
INBS Stock Surges 132.4% on New Manufacturing Partnership
NASDAQ · 4d ago
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
PR Newswire · 4d ago
A Look Into Boston Scientific Inc's Price Over Earnings
Benzinga · 5d ago
All J.P. Morgan's top stock picks for 2026
Seeking Alpha · 12/31/2025 17:44
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
NASDAQ · 12/31/2025 15:52
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform
NASDAQ · 12/31/2025 15:49
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
NASDAQ · 12/31/2025 12:31
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?
NASDAQ · 12/31/2025 12:21
ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction
NASDAQ · 12/30/2025 17:45
BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now?
NASDAQ · 12/30/2025 13:20
The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price
Seeking Alpha · 12/29/2025 22:28
Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA
NASDAQ · 12/29/2025 15:57
Peter Lynch Detailed Fundamental Analysis - BSX
NASDAQ · 12/29/2025 14:00
Weekly Report: what happened at BSX last week (1222-1226)?
Weekly Report · 12/29/2025 09:42
Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside
Seeking Alpha · 12/28/2025 07:40
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.